Clinical Trial Results:
An 8-Week, Multicenter, Masked, Randomized Trial (with an 18-Week Masked Extension) to Assess the Safety and Efficacy of 700 µg and 350 µg Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS) Applicator System Compared with Sham DEX PS DDS Applicator System in the Treatment of Non Infectious Ocular Inflammation of the Posterior Segment in Patients with Intermediate or Posterior Uveitis
Summary
|
|
EudraCT number |
2006-000736-26 |
Trial protocol |
GB AT IT PT BE CZ DE GR ES |
Global completion date |
28 Apr 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
03 Nov 2016
|
First version publication date |
03 Nov 2016
|
Other versions |
|
Summary report(s) |
CT.gov Summary Results - Study 206207-014 - Eudra 2006-000736-26 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.